论文部分内容阅读
白血病/淋巴瘤体内微小残留病变(MRD)是指临床上病情达到完全缓解,而体内仍有微量的仅凭形态学方法无法检测的白血病细胞残留,MRD是白血病/淋巴瘤复发的主要根源。亦成为白血病/淋巴瘤防止复发的关键问题。树突状细胞(DC)是目前所知的体内功能最强的专职性抗原提呈细胞(APC),它
Leukemia / Lymphoma The minimal residual disease (MRD) is the complete remission of the disease in clinical practice. However, there are still a few residual leukemia cells in the body that can not be detected by morphological methods. MRD is the main source of leukemia / lymphoma recurrence. It has also become a key issue in preventing leukemia / lymphoma recurrence. Dendritic cells (DCs) are the most potent professional antigen-presenting cells (APCs) in the body known to date